Leef Brands (LEEEF) Operating Income (2025 - 2026)

Leef Brands (LEEEF) reported Operating Income of $1.3 million for Q1 2026, up 167.29% on a YoY basis from $480245.0 in Q1 2025, and up 167.29% sequentially from -$1.9 million in Q1 2025.

Leef Brands (LEEEF) Operating Income (2025 - 2026) Analysis & Trends

Leef Brands (LEEEF) has 2 years of Operating Income data on file, last reported at $1.3 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn 652.00 Mn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn 833.00 Mn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn -2.65 Bn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn 325.80 Mn
6 RedHill Biopharma 21.32 Bn 21.32 Bn - -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn -79.70 Mn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 193.40 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn 291.00 Mn
10 Leef Brands 51.81 Mn 46.05 Mn 4.62 Mn 1.28 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.28 Mn
Mar 31, 2025 -1.91 Mn